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Vaccinating with conserved Escherichia 
coli antigens does not alter the mouse  
intestinal microbiome
Michael P. Hays1, Aaron C. Ericsson2, Yang Yang1 and Philip R. Hardwidge1* 
Abstract 
Background: Enterotoxigenic Escherichia coli (ETEC) causes diarrheal disease. Antigenic and structural heterogene-
ity among ETEC colonization factors has complicated vaccine development efforts. Identifying and characterizing 
conserved ETEC antigens that induce protective immunity is therefore of interest. We previously characterized three 
proteins (MipA, Skp, and ETEC_2479) that protected mice in an intranasal ETEC challenge model after vaccination. 
However, these proteins are conserved not only in multiple ETEC isolates, but also in commensal bacteria. While the 
impact of inactivated viral vaccines and live-attenuated bacterial vaccines on the host microbiota have been exam-
ined, the potential impact of using subunit vaccines consisting of antigens that are also encoded by commensal 
organisms has not been investigated.
Findings: We addressed this issue by characterizing changes to mouse intestinal microbiomes as a function of vac-
cination. We failed to observe significant changes to mouse health, to mouse weight gain as a function of time, or to 
the diversity or richness of mouse intestinal microbiomes, as measured by analyzing alpha- and beta-diversity, as well 
as overall community structure, before and after vaccination.
Conclusions: We conclude that despite the conservation of MipA, Skp, and ETEC_2479 among Gram-negative bac-
teria, vaccination with these antigens fails to alter significantly the host intestinal microbiome.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Enterotoxigenic Escherichia coli (ETEC) causes hun-
dreds of millions of cases of diarrhea annually, particu-
larly in developing countries [1]. In addition to their 
acute impact on human health, repeated infections also 
contribute to delayed growth and malnutrition [1]. Many 
vaccine strategies have focused on ETEC colonization 
factors (CFs). These heterogeneous surface structures 
function in attachment by binding to host glycoprotein 
conjugates [2]. Numerous CFs have been described, but 
many ETEC strains do not produce a recognizable CF [3]. 
A need therefore exists to identify new vaccine targets 
that are independent of strain-specific CFs.
We previously characterized three ETEC H10407 pro-
teins as protective antigens in a mouse model involving 
intranasal bacterial challenge [4]. Antisera raised against 
the ETEC MipA, Skp, and ETEC_2479 proteins protected 
HCT-8 cells from attachment by multiple ETEC strains 
[4]. Immunization with these antigens also protected 
mice from an otherwise lethal challenge with intranasally 
administered ETEC H10407 [4]. Skp is a molecular chap-
erone that rescues misdirected outer membrane proteins 
[5]. MipA is an immunoreactive protein [6] that belongs 
to a family of proteins involved in remodeling peptidogly-
can. ETEC_2479 is predicted to function as an outer 
membrane porin involved in long chain fatty acid trans-
port [7]. The intranasal challenge model [8, 9] is a useful 
alternative for ETEC vaccine studies because mice do not 
naturally develop diarrheal disease after oral ETEC chal-
lenge [10]. This model also permits the quantification of 
mouse survival, bacterial clearance, and host immune 
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responses, and stimulates mucosal immune responses, 
especially secretory IgA (sIgA) responses that are impor-
tant to blocking bacterial adherence to mucosal surfaces.
Identifying broadly conserved, protective antigens is 
important to vaccine development. However, MipA, Skp, 
and ETEC_2479 are conserved not only among patho-
genic ETEC strains, but also among the commensal Pro-
teobacteria. This may be an important issue because it 
is known that alteration of commensals can influence 
susceptibility to gastrointestinal disease [11] and vac-
cine efficacy [12]. Several previous studies have begun to 
address this issue. Rotavirus vaccination of humans did 
not have a major impact to infant microbiomes [13]. A 
challenge of cynomolgus macaques with an oral-live 
attenuated Shigella strain found a possible protective 
role for the microbiota and highlighted the importance 
of considering host genetics in vaccine studies [14]. Oral 
immunization with the live-attenuated typhoid vaccine 
strain Ty21a did not cause significant perturbation of the 
fecal microbiota related to vaccine administration [15]. 
Thus, while the impact of inactivated viral vaccines and 
live-attenuated bacterial vaccines on the host microbiota 
have been examined, the potential impact of using subu-
nit vaccines consisting of antigens that are also encoded 
by commensal organisms has not been investigated.
We hypothesized that using the conserved antigens 
MipA, Skp, and ETEC_2479 as subunit vaccine candi-
dates could negatively impact the health of the host by 
affecting the intestinal microbiota. Herein, we tested and 
subsequently refuted this hypothesis.
Methods
Ethics statement
Animal experiments were performed according to Kan-
sas State University Institutional Animal Care and Use 
Committee-approved protocols (IACUC #3648). This 
institution complies with all applicable provisions of the 
Animal Welfare Act and other Federal statutes and regu-
lations relating to animals.
Antigen purification
Escherichia coli BL21(DE3) strains expressing individual 
antigens were grown overnight as described [4]. After 
purification, proteins were dialyzed into glycerol in Pierce 
Slide-A-Lyzer dialysis cassettes. Protein concentrations 
were quantified by using the Precision Red Advanced 
Protein Assay (Cytoskeleton, Inc.).
Polyclonal antisera production
Female BALB/c mice of matched age (6  weeks at initial 
vaccination) were obtained from the Jackson Laboratory 
(Bar Harbor, Maine) and handled as described previously 
[4]. Mice were housed (5 per group) in microisolator 
cages (1 cage per group) and provided with food and 
water ad libitum. Antigens (20 µg/dose) were mixed with 
2.5 µg of cholera toxin in 25 µl phosphate-buffered saline 
(PBS) and then administered intranasally to the external 
nares of mice that had been anesthetized with isoflu-
rane [4]. Two booster doses were administered, at 2- and 
4-weeks after the initial vaccination. Mice were eutha-
nized 2 weeks after the final immunization and exsan-
guinated. The blood was processed into serum using 
centrifugation for 2 min at 2500g in a BD microcontainer 
serum separator tube. Control serum samples were also 
obtained from mice immunized with PBS or with EHEC 
EspB.
Immunoassays
Enzyme-linked immunosorbent assays (ELISAs) were 
performed as previously described [4], using serial dilu-
tions of mouse serum samples and polystyrene 96-well, 
flat bottom plates (Whatman) coated with purified anti-
gens or with bovine serum albumin (BSA; 0.5  µg/ml). 
Plates were developed with 1-StepTM Ultra TMB-ELISA 
(Thermo) and quenched with 3  N H2SO4. Absorbance 
was read at 450 nm.
Fecal DNA extraction
A fecal pellet from each mouse was collected weekly, with 
the initial collection prior to the first vaccination and 
the final collection 2  weeks after the final vaccination. 
After collection, the fecal pellets were stored at −80  °C 
until DNA extraction could be performed. Prior to DNA 
extraction using QIAamp DNA Stool Mini Kits (Qiagen), 
1.4 ml of Buffer ASL was added to fecal samples on ice. 
Fecal pellets were vortexed until completely resuspended 
and DNA was extracted by following the manufacturer’s 
protocol.
Library construction and sequencing
Library construction and sequencing was performed 
essentially as described [16]. Prior to PCR, DNA concen-
trations were determined via fluorometry (Qubit dsDNA 
BR assay, Life Technologies, Carlsbad, CA) and normal-
ized to a standard concentration. Bacterial Microbial 
16S rRNA amplicons were generated via amplification of 
the V4 hypervariable region of the 16S rRNA gene using 
single-indexed universal primers as described previously 
[U515F/806R; 17] flanked by Illumina standard adapter 
sequences. Primer sequences are available at proBase [18; 
http://www.microbial-ecology.net/probebase/]. PCR was 
performed using the following parameters: 98  °C(3:00) +   
[98 °C(0:15) + 50 °C(0:30) + 72 °C(0:30)] × 25 cycles +72 °C(7:00). 
Following PCR, amplicons were pooled for sequencing 
using the Illumina MiSeq platform and V2 chemistry 
with 2 × 250 bp paired-end reads.
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Informatics analysis
Informatics analysis was performed essentially as 
described [16]. FLASH software was used to assemble 
contiguous DNA sequences [18]. Sequences were culled 
if determined to be short after trimming for a base qual-
ity less than 31. Reference-based and de novo chimera 
detection and removal was conducted using Qiime v1.8 
software [19]. Remaining contiguous sequences were 
assigned to operational taxonomic units (OTUs) via de 
novo clustering with a criterion of 97 % nucleotide iden-
tity as described [16]. Annotation of selected OTUs was 
performed using BLAST [20] against the Greengenes 
database [21] of 16S rRNA sequences and taxonomy. 
Principal component analysis was performed using ¼ 
root-transformed OTU relative abundance data via a 
non-linear iterative partial least squares (NIPALS) algo-
rithm, implemented using an open access Excel macro 
available from the Riken Institute (http://prime.psc.riken.
jp/Metabolomics_Software/StatisticalAnalysisOnMicro-
softExcel/index.html). Sequence data were deposited in 
the NCBI Sequence Read Archive (SRA) under the Bio-
ProjectID PRJNA320839.
Statistical analyses
Statistical analysis was performed using Sigma Plot 12.3 
(Systat Software Inc., Carlsbad, CA). Interactions and 
differences between treatment groups and time-points 
in Chao1 indices were determined using 2-way analysis 
of variance (ANOVA). Analysis of molecular variance 
(AMOVA) was implemented in a general linear model 
using SPSS software, version 23 (IBM, Armonk, NY). 
Results were considered statistically significant for p val-
ues ≤0.05.
Results
Mice were vaccinated intranasally with purified, recom-
binant forms of ETEC MipA, Skp, and ETEC_2479 
[4], as well as with a purified, recombinant form of E. 
coli O157:H7 EDL933 EspB [22]. EspB was used as an 
external control because it is immunogenic but is not 
expressed by either ETEC or by commensal bacteria 
[23]. After 3 immunizations, mice were sacrificed and 
their serum was used in ELISAs to quantify antibody 
titers. All mice (5/group) produced detectable IgG titers 
(Fig. 1a). Mouse health and weight gain were monitored 
during the vaccination regimen. Neither obvious changes 
to mouse health or behavior, nor changes in the rate of 
weight gain were observed. The weights of the mice after 
vaccination were 21.1 ± 1.0 g for the PBS control group, 
20.7 ± 1.0 g for EspB, 21.2 ± 0.9 g for MipA, 21.2 ± 2.0 g 
for Skp, and 21.3 ± 0.9 g for ETEC_2479 (p > 0.05). Fecal 
IgA responses for mice immunized with either MipA, 
Skp, or ETEC_2479 ranged from a 13.2 ± 2.2, 13.0 ± 3.4, 
and 26.8  ±  4.6 fold-increase as compared with control 
groups, respectively [4].
To determine whether vaccination affected the diver-
sity and overall composition of the mouse intestinal 
microbiota, 16S rRNA amplicon sequencing was per-
formed using DNA extracted from feces collected prior 
to vaccination, from the mid-point of the vaccination 
regimen (after the second vaccination), and two weeks 
after the final vaccination, as template. Following vacci-
nation, there were no apparent differences in the micro-
bial profiles when resolved to the level of operational 
taxonomic unit (OTU), and the same six OTUs (fami-
lies S24-7, Lachnospiraceae, Ruminococcaceae, order 
Clostridiales, Oscillospira sp., and Anaeroplasma sp.) 
dominated the pre- and post-vaccination microbiota of 
all groups (Fig. 1b). Regarding the effect of vaccination on 
other Gram-negative taxa that potentially express the tar-
geted antigens, i.e., microbes in the order Bacteroidales 
or phylum Proteobacteria, no differences were detected 
between pre- and post-vaccination samples in the relative 
abundance of these bacteria (Fig. 1c). The Chao1 index, 
a measure of α-diversity (i.e., within samples), was also 
compared between groups to determine if vaccination 
affected the richness or distribution of microbes. Two-
way ANOVA detected no significant differences between 
groups, or between pre- and post-vaccination samples 
(Fig.  2a). Samples obtained from the mid-point of the 
vaccination regimen (after the second vaccination) were 
also analyzed and were not significantly different from 
pre-or post-vaccination samples (Fig. 2a). Similarly, nei-
ther the Shannon diversity index, nor the raw number of 
unique sequences detected in each group, were signifi-
cantly different among groups (Fig. 2b, c).
Principal component analysis (PCA) was performed 
both to assess β-diversity (i.e., between samples) and to 
determine if vaccination induced changes in the over-
all composition of the microbiota. No clustering of 
post-vaccination samples was observed in plots of prin-
cipal component 1 (PC1) against PC2 or PC3, which 
accounted collectively for over 60  % of the variability 
between samples, suggesting that there were negligible 
shifts in the bacterial community composition of any 
treatment group (Fig.  3a). A comparison of the mean 
intragroup unweighted UniFrac distance between pre- 
and post-vaccination samples detected no greater dis-
similarity between the two samples in treated groups as 
compared to the control group, as determined by per-
forming ANOVA with post hoc Dunnett’s tests (Fig. 3b). 
Supporting our prior analysis, AMOVA detected no 
significant effect of vaccination treatment (p  =  0.053; 
F value =  3.302), and also no significant effect of time-
point (p = 0.359; F value = 4.517), using the first and last 
samples as time-points.
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Discussion
The discovery and characterization of broadly con-
served ETEC vaccine antigens that are independent of 
strain-specific CFs is of emerging interest. However, 
an important consideration is whether targeting anti-
gens also expressed by commensal flora will negatively 
impact host health or vaccine efficacy. We have charac-
terized the ETEC proteins MipA, Skp, and ETEC_2479 
for their protective efficacy in an intranasal challenge 
model. These proteins are highly conserved not only in 
diverse ETEC isolates, but also in commensal Proteo-
bacteria and other E. coli and Shigella strains, sharing 
~99 % identity with the corresponding Shigella proteins. 
Because altering commensal abundance and diversity 
may affect host health and vaccine efficacy, we were 
therefore interested in determining whether using these 
antigens in a subunit vaccine would affect the mouse 
microbiota. Commensal E. coli strains may contribute 
to colonization resistance against pathogens [24]. For 
example, E. coli Nissle 1917 has been extensively char-
acterized as a probiotic agent [25] and could potentially 
function by competing for nutrients that are required 
by pathogens [24]. They also play important, though 
incompletely defined roles in maintaining intestinal 
homeostasis [26].
We did not observe changes to mouse health, behavior, 
or rate of weight gain following intranasal vaccination 









































































































































































Fig. 1 Vaccination with ETEC MipA, Skp, and ETEC_2479. a Serum IgG responses in mice. Data are plotted as the fold-change in serum IgG after 
immunization with the indicated antigens, n = 5/group. b Bar chart showing relative abundance of all operational taxonomic units (OTUs) detected 
in the feces of mice prior to (pre) and 6 weeks after (post) vaccination with the indicated antigens, as detected using 16S rRNA amplicon sequenc-
ing. The identities of dominant taxa are shown at the right. c Mean number + standard deviation (SD) of sequence reads that were specific to 
Bacteriodales or Proteobacteria in indicated treatment groups
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no significant differences among the microbial profiles 
when resolved to the level of operational taxonomic 
unit (OTU), as determined by performing 16S rRNA 
amplicon sequencing. Analysis of the Chao1 index, the 
Shannon diversity index, and the raw number of unique 
sequences detected in each treatment group, also failed 
to reveal any significant differences. PCA analysis and 
comparison of UniFrac distances also suggested negligi-
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Fig. 2 Sequence diversity among treatment groups. a Bar chart showing mean + standard deviation (SD) Chao1 a-diversity index of fecal micro-
biota in mice pre- and post-vaccination with the indicated antigens, as detected using 16S rRNA amplicon sequencing. b Mean Shannon diversity 
indices. c Mean number of unique sequences in treatment groups
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While no consistent shifts in the composition of the 
fecal microbiota were detected following vaccination 
against the three conserved candidate antigens, a closer 
examination of the effects of vaccination on the relative 
abundance of taxa expected to express these antigens, i.e., 
bacteria within order Bacteroidales and phylum Proteo-
bacteria, was performed. While no vaccination-depend-
ent differences were detected in the relative abundance 
of these groups, we recognize that both Bacteroidales 
and Proteobacteria are rare taxa in the current samples. 
This is not however unique to this cohort of mice, as we 
have demonstrated very comparable levels of these taxa 
in multiple genetic backgrounds of mice purchased from 
the same vendor and the overwhelming majority of gut 
bacteria in most research mice are Gram-positive [27]. 
Regardless, the low numbers of Gram-negative bacteria 
present in the present cohorts were not affected by vac-
cination. It will be important in future studies to validate 
these studies using diarrheal disease models for ETEC in 
either mice or piglets.
Overall, despite the conservation of MipA, Skp, and 
ETEC_2479 among Gram-negative bacteria, vaccination 
with these antigens fails to alter significantly the host 
intestinal microbiota and suggests that their inclusion in 
future ETEC vaccine preparations may be efficacious.
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Fig. 3 Principal component analyses and UniFrac distances. a Unweighted principal component analyses showing β-diversity of fecal microbiota 
in mice pre- and post-vaccination with the indicated antigens, as detected via 16S rRNA amplicon sequencing. Principal component 1 (PC1) versus 
PC2 (left) and PC1 versus PC3 (right) are shown. Color-coding is identical to Fig. 2, with open symbols representing pre-vaccination and closed symbols 
representing post-vaccination samples. b Mean intragroup unweighted UniFrac distances between pre- and post-vaccination samples
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